XML 24 R9.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Cash collections from financial royalty assets $ 2,315,854 $ 2,121,923 $ 1,934,092
Cash collections from intangible royalty assets 151,158 143,753 143,298
Other royalty cash collections 44,123 18,305 27,448
Distributions from non-consolidated affiliates 34,384 42,334 14,059
Interest received 3,135 7,704 20,136
Derivative collateral received 34,660 45,252 360
Derivative collateral posted (34,660) 0 (45,630)
Termination payments on derivative instruments (16,093) (35,448) 0
Ongoing development-stage funding payments (6,876) (20,479) (83,036)
Upfront development-stage funding payments (193,208) (5,810) 0
Payments for operating and professional costs (184,511) (179,709) (88,524)
Interest paid (130,430) (103,196) (254,964)
Net cash provided by operating activities 2,017,536 2,034,629 1,667,239
Cash flows from investing activities:      
Distributions from non-consolidated affiliates 523 15,084 0
Investments in non-consolidated affiliates (34,855) (40,155) (27,042)
Purchases of equity securities (135,134) (50,000) (78,999)
Proceeds from equity securities 115,957 384,840 0
Purchases of available for sale debt securities (70,441) 0 (125,121)
Proceeds from available for sale debt securities 62,500 3,000 150,000
Purchases of marketable securities (1,196,579) (1,705,283) (817,402)
Proceeds from sales and maturities of marketable securities 1,597,851 815,440 725,070
Purchase of warrants 0 0 (8,840)
Acquisitions of financial royalty assets (2,191,502) (2,182,246) (1,721,291)
Milestone payments (18,600) 0 (250,000)
Net cash used in investing activities (1,870,280) (2,759,320) (2,153,625)
Cash flows from financing activities:      
Distributions to shareholders/unitholders 0 (285,353) (739,276)
Distributions to non-controlling interest (479,604) (543,952) (154,084)
Distributions to non-controlling interest- other (153,800) (181,135) 0
Dividends to shareholders (285,184) (112,490) 0
Contributions from non-controlling interest- R&D 7,339 8,482 0
Contributions from non-controlling interest- other 36,874 58,957 0
Scheduled repayments of long-term debt 0 (94,200) (294,000)
Repayments of long-term debt 0 (11,116,196) 0
Proceeds from issuance of long-term debt, net of discount 1,272,533 11,891,030 0
Debt issuance costs and other (13,046) (46,715) 0
Purchase of treasury interests 0 0 (4,266)
Proceeds from issuance of Class A ordinary shares upon IPO, net of offering costs 0 1,908,744 0
Net cash provided by/(used in) financing activities 385,112 1,487,172 (1,191,626)
Net change in cash and cash equivalents 532,368 762,481 (1,678,012)
Cash and cash equivalents, beginning of year 1,008,680 246,199 1,924,211
Cash and cash equivalents, end of year $ 1,541,048 $ 1,008,680 $ 246,199